title: [How to choose the optimal therapy? New issues in the treatment of metastatic melanoma].
abstract: The last few years brought about a complete paradigm-shift in the field of melanoma therapy: eight new drugs, including three immunooncologic, four targeted and one oncolytic virus, became available in the daily practice. These new treatments provide a significantly increased overall survival potential for patients with metastatic melanoma. Choosing the optimal treatment for the individual patient, however, requires the careful evaluation of several patient- and drug-related factors, and poses a great challenge for the oncologists. This review summarizes the practical aspects of the selection of the optimal melanoma treatment.
authors.affiliation: Bõrgyógyászati és Allergológiai Klinika, Szegedi Tudományegyetem, Szeged, Hungary. lazarne.olah.judit@med.u-szeged.hu.
authors.forename: Judit
authors.initials: J
authors.lastname: Oláh
authors.affiliation: Bõr-, Nemikórtani és Onkodermatológiai Klinika, Pécsi Tudományegyetem, Pécs, Hungary.
authors.forename: Rolland
authors.initials: R
authors.lastname: Gyulai
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018572:Disease-Free Survival; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008545:Melanoma / Q000628:therapy*; D016609:Neoplasms, Second Primary; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents